Beckman Targets Rivals ABI, GE, Agilent With Gene-Expression Product Launch | GenomeWeb

In its ongoing quest to delve into new markets, Beckman Coulter has introduced a high-throughput quantitative gene-expression instrument, taking aim at a market dominated by Affymetrix and joining many others who have flooded the space over the past few years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.